Federated Hermes
QTTB icon

Federated Hermes’s Q32 Bio QTTB Stock Holding History

Federated Hermes’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6K Hold
2,273
– – ﹤0.01% 1817
2025
Q4 		$7.55K Sell
2,273
-101
-4% -$285 ﹤0.01% 1858
2025
Q3 		$4.7K Sell
2,374
-78
-3% -$150 ﹤0.01% 1948
2025
Q2 		$3.65K Sell
2,452
-30
-1% -$51 ﹤0.01% 1915
2025
Q1 		$4.09K Buy
2,482
+2,025
+443% +$5.45K ﹤0.01% 1898
2024
Q4 		$1.57K Buy
457
+349
+323% +$11K ﹤0.01% 1997
2024
Q3 		$4.82K Buy
+108
New +$3.97K ﹤0.01% 1862
2023
Q1 		– Sell
-16
Closed -$367 – 2282
2022
Q4 		$367 Buy
16
+5
+45% +$133 ﹤0.01% 2103
2022
Q3 		$1K Buy
+11
New +$449 ﹤0.01% 2094
2022
Q2 		– Sell
-334
Closed -$18K – 2304
2022
Q1 		$18K Sell
334
-219
-40% -$13.6K ﹤0.01% 1833
2021
Q4 		$36K Buy
553
+549
+13,725% +$53.3K ﹤0.01% 1824
2021
Q3 		$1K Sell
4
-23,709
-100% -$3.02M ﹤0.01% 2171
2021
Q2 		$3.1M Buy
+23,713
New +$2.96M 0.01% 969
2019
Q2 		– Sell
-7
Closed -$3K – 2233
2019
Q1 		$3K Hold
7
– – ﹤0.01% 2044
2018
Q4 		$3K Sell
7
-1
-13% -$378 ﹤0.01% 2056
2018
Q3 		$3K Buy
+8
New +$2.72K ﹤0.01% 2121

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes's QTTB Position: Q1 2026 in Review

Federated Hermes held its Q32 Bio (QTTB) position steady in Q1 2026 at 2,273 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Federated Hermes first reported a position in QTTB in Q3 2018 and has held it in 16 quarters since. The position peaked at $3.1M in Q2 2021. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Federated Hermes held 2,273 shares of Q32 Bio worth $14.6K as of Q1 2026.
  • Federated Hermes left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1817 holding.
  • Federated Hermes first reported a position in Q32 Bio in Q3 2018 and has held it in 16 quarters since.
  • Federated Hermes's Q32 Bio position peaked at $3.1M in Q2 2021.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.